New advances and challenges of targeting cancer stem cells

Nurmaa K. Dashzeveg, Rokana Taftaf, Erika K. Ramos, Luke Torre-Healy, Anastasia Chumakova, Daniel J. Silver, Tyler J. Alban, Maksim Sinyuk, Praveena S. Thiagarajan, Awad M. Jarrar, Soumya M. Turaga, Caner Saygin, Erin Mulkearns-Hubert, Masahiro Hitomi, Jeremy N. Rich, Stanton L. Gerson, Justin D. Lathia, Huiping Liu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20–23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists.

Original languageEnglish (US)
Pages (from-to)5222-5227
Number of pages6
JournalCancer Research
Issue number19
StatePublished - Oct 1 2017

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'New advances and challenges of targeting cancer stem cells'. Together they form a unique fingerprint.

Cite this